Thursday, 15 October 2026European Markets

ITERA And ASM INTERNATIONAL Have A High Dividend Yield And Return On Equity In The Technology Sector.

Loading stream...

(VIANEWS) - ITERA (ITERA.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Technology sector.

Financial Asset Price Forward Dividend Yield Return on Equity
ITERA (ITERA.OL) kr11.25 3.54% 63.44%
ASM INTERNATIONAL (ASM.AS) €573.40 0.49% 17.12%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. ITERA (ITERA.OL)

3.54% Forward Dividend Yield and 63.44% Return On Equity

Itera ASA, together with its subsidiaries, develops and operates digital solutions for businesses and organizations in Norway, Sweden, Ukraine, Denmark, Czech Republic, Iceland, Poland, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company provides a range of services in the strategy and consulting, customer experience, and technology and cloud transformation areas. It serves banking and insurance, energy and utilities, industry and manufacturing, health and public services, technology and communication, and products and retail industries. The company was founded in 1989 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, ITERA has a trailing twelve months EPS of kr0.57.

PE Ratio

ITERA has a trailing twelve months price to earnings ratio of 19.74. Meaning, the purchaser of the share is investing kr19.74 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 63.44%.

Moving Average

ITERA's value is below its 50-day moving average of kr11.48 and below its 200-day moving average of kr11.83.

More news about ITERA.

2. ASM INTERNATIONAL (ASM.AS)

0.49% Forward Dividend Yield and 17.12% Return On Equity

ASM International NV, together with its subsidiaries, engages in the research, development, manufacture, marketing, and servicing of equipment and materials used to produce semiconductor devices in Europe, the United States, and Asia. The company's products include wafer processing deposition systems for atomic layer deposition (ALD), epitaxy, silicon carbide, plasma enhanced chemical vapor deposition (PECVD), and vertical furnace systems, including low pressure chemical vapor deposition (LPCVD), diffusion, and oxidation products, as well as provides spare parts and support services. It also manufactures and sells equipment, which is used in wafer processing, encompassing the fabrication steps in which silicon wafers are layered with semiconductor devices. The company offers its products to semiconductor manufacturers. The company was formerly known as Advanced Semiconductor Materials International NV. ASM International NV was incorporated in 1968 and is headquartered in Almere, the Netherlands.

Earnings Per Share

As for profitability, ASM INTERNATIONAL has a trailing twelve months EPS of €11.16.

PE Ratio

ASM INTERNATIONAL has a trailing twelve months price to earnings ratio of 51.38. Meaning, the purchaser of the share is investing €51.38 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.12%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on May 15, 2024, the estimated forward annual dividend rate is 2.75 and the estimated forward annual dividend yield is 0.49%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ASM INTERNATIONAL's stock is considered to be oversold (<=20).

More news about ASM INTERNATIONAL.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com